National Comprehensive Cancer Network



About NCCN

Prevention and Treatment of Cancer-Related Infections Panel - Disclosures as of 5/24/2013

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Michael Angarone, DO

None

None

None

None

8/14/2012

Lindsey Robert Baden, MD

NIH funded research

None

None

None

12/5/2012

William Bensinger, MD

Celgene Corporation;
Millennium Pharmaceuticals, Inc.;
Novartis Pharmaceuticals Corporation;
Onyx Pharmaceuticals, Inc.;
Pharmacyclics

Celgene Corporation;
Millennium Pharmaceuticals, Inc.

None

None

4/5/2013

Corey Casper, MD, MPH

None

None

None

None

4/22/2013

Erik R. Dubberke, MD

Merck & Co., Inc.;
Chimerix;
optimer;
Viropharma;
sanofi-aventis U.S.

Merck & Co., Inc.;
;
Optimer;
Pfizer Inc.;
sanofi-aventis U.S.

None

None

12/11/2012

Alison G. Freifeld, MD

None

None

None

None

11/2/2012

Ramiro Garzon, MD

None

None

None

None

8/18/2012

John N. Greene, MD

None

None

None

None

9/20/2012

John P. Greer, MD

None

None

None

None

10/8/2012

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

10/23/2012

James I. Ito, MD

Astellas;
Roche Laboratories, Inc.

Merck & Co., Inc.;
Astellas;
Sigma Tau

None

None

12/12/2012

Daniel R. Kaul, MD

Chimerix

None

None

None

8/19/2012

Earl King, MD

None

None

None

None

12/3/2009

Emily R. Mackler, PharmD, BCOP

None

None

None

None

10/17/2012

Kieren A. Marr, MD

Merck & Co., Inc.;
Astellas;
Pfizer Inc.

Merck & Co., Inc.;
Optimer;
Pfizer Inc.

None

None

12/6/2012

Joan S. McClure, MS

None

None

None

None

7/23/2012

Jose G. Montoya, MD

None

None

None

None

11/5/2012

Ashley Morris Engemann, PharmD, BCOP

None

None

None

None

3/5/2012

Maoko Naganuma, MSc

None

None

None

None

2/28/2013

Peter G. Pappas, MD

Merck & Co., Inc.;
Pfizer Inc.

Astellas

None

None

4/20/2010

Ken Rolston, MD

Merck & Co., Inc.

None

None

None

12/10/2012

Brahm Segal, MD

Astellas

Merck & Co., Inc.

None

None

11/10/2012

Susan K. Seo, MD

None

None

None

None

10/8/2012

Dorothy Shead, MS

None

None

None

None

8/3/2012

Sankar Swaminathan, MD

None

None

Bristol-Myers Squibb Company;
Johnson & Johnson;
Optimer Pharmaceuticals;
Pfizer Inc.

None

10/13/2012

 

About NCCN| NCCN Member Institutions| Patient Resources| NCCN Foundation| Privacy Policy| Legal Notices| Contact Us

275 Commerce Drive, Suite 300, Fort Washington, PA 19034 • 215.690.0300 • Fax: 215.690.0260
Copyright © 2012 National Comprehensive Cancer Network, All Rights Reserved